Trial NCT03840902

View at ClinicalTrials.gov 
Org. Study IDs: MS200647_0005
Secondary IDs: 2018-003265-34

Last trial update was posted on 2024-01-16

MeSH Interventions

Carboplatin Durvalumab Etoposide Paclitaxel Pemetrexed

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer

Stopping Reasons

Based on recommendations by an external Independent data Monitoring Committee (IDMC), Sponsor decided to discontinue this clinical study due to a low likelihood of achieving superiority in the efficacy endpoints versus standard of care.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID